The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Losartan prevents acquired epilepsy via TGF‐β signaling suppression
Open accessAbstract
Objective: Acquired epilepsy is frequently associated with structural lesions after trauma, stroke, and infections. Although seizures are often difficult to treat, there is no clinically applicable strategy to prevent the development of epilepsy in patients at risk. We have recently shown that vascular injury is associated with activation of albumin‐mediated transforming growth factor β (TGF‐β) signaling, and followed by local inflammatory response and epileptiform activity ex vivo. Here we investigated albumin‐mediated TGF‐β signaling and tested the efficacy of blocking the TGF‐β pathway in preventing epilepsy. Methods: We addressed the role of TGF‐β signaling in epileptogenesis in 2 different rat models of vascular injury, combining in vitro and in vivo biochemical assays, gene expression, and magnetic resonance and direct optical imaging for blood–brain barrier permeability and vascular reactivity. Long‐term electrocorticographic recordings were acquired in freely behaving animals. Results: We demonstrate that serum‐derived albumin preferentially induces activation of the activin receptor‐like kinase 5 pathway of TGF‐β receptor I in astrocytes. We further show that the angiotensin II type 1 receptor antagonist, losartan, previously identified as a blocker of peripheral TGF‐β signaling, effectively blocks albumin‐induced TGF‐β activation in the brain. Most importantly, losartan prevents the development of delayed recurrent spontaneous seizures, an effect that persists weeks after drug withdrawal. Interpretation: TGF‐β signaling, activated in astrocytes by serum‐derived albumin, is involved in epileptogenesis. We propose losartan, a drug approved by the US Food and Drug Administration, as an efficient antiepileptogenic therapy for epilepsy associated with vascular injury. Ann Neurol 2014;75:864–875
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, in vivo pharmacological blockade of TGFβRI/II using SB431542 and losartan19,20 decreases Smad2/3 signaling in the peri-infarct tissue (Supplementary Fig. 5) during the period of GDF activity after stroke.”
From GDF10 is a signal for axonal sprouting and functional recovery after stroke (2015) · cites this paper as [19]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Learning representations by back-propagating errors
Rumelhart, D. E., Hinton, G. E., & Williams, R. J. (1986) · Nature · doi:10.1038/323533a0 · Cited by 31,892
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,860
Astrocyte-endothelial interactions at the blood-brain barrier
Abbott, N. J., Rönnbäck, L., & Hansson, E. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1824 · Cited by 5,595
Structure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
TGF-β signalling from cell membrane to nucleus through SMAD proteins
Heldin, C., Miyazono, K., & ten Dijke, P. (1997) · Nature · doi:10.1038/37284 · Cited by 3,697
Massagué, J. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3434 · Cited by 3,239
Massagué, J. (2000) · Nature Reviews Molecular Cell Biology · doi:10.1038/35043051 · Cited by 1,925
The role of inflammation in epilepsy
Vezzani, A., French, J., Bartfai, T., & Baram, T. Z. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.178 · Cited by 1,876
Comprehensive Algorithm for Quantitative Real-Time Polymerase Chain Reaction
Zhao, S., & Fernald, R. D. (2005) · Journal of Computational Biology · doi:10.1089/cmb.2005.12.1047 · Cited by 1,314
Restart procedures for the conjugate gradient method
Powell, M. J. D. (1977) · Mathematical programming · doi:10.1007/bf01593790 · Cited by 1,252
Flagged first, then by citations
Cited by
Sorted by citations
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 967
Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy
Vezzani, A., Balosso, S., & Ravizza, T. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-019-0217-x · Cited by 928
Neuron–glia interactions in the pathophysiology of epilepsy
Patel, D. C., Tewari, B. P., Chaunsali, L., & Sontheimer, H. W. (2019) · Nature reviews. Neuroscience · doi:10.1038/s41583-019-0126-4 · Cited by 478
Tagge, C. A., Fisher, A. M., Minaeva, O. V., Gaudreau, A., Moncaster, J. A., Zhang, X.-L., Wojnarowicz, M. W., Casey, N. F., Lu, H., Kokiko‐Cochran, O. N., et al. (2017) · Brain · doi:10.1093/brain/awx350 · Cited by 402
Self-citationCommonalities in epileptogenic processes from different acute brain insults: Do they translate?
Klein, P., Dingledine, R. J., Aronica, E., Bernard, C., Blümcke, I., Boison, D., Brodie, M. J., Brooks‐Kayal, A. R., Engel, J., Forcelli, P. A., et al. (2017) · Epilepsia · doi:10.1111/epi.13965 · Cited by 300
Weissberg, I., Wood, L., Kamintsky, L., Vazquez, O. N., Milikovsky, D. Z., Alexander, A., Oppenheim, H., Ardizzone, C., Becker, A. J., Frigerio, F., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.02.029 · Cited by 291
Self-citationInflammatory mediators in human epilepsy: A systematic review and meta-analysis
de Vries, E. E., van den Munckhof, B., Braun, K. P. J., van Royen‐Kerkhof, A., de Jager, W., & Jansen, F. E. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.02.007 · Cited by 271
Senatorov, V. V., Friedman, A. R., Milikovsky, D. Z., Ofer, J., Saar-Ashkenazy, R., Charbash, A., Jahan, N., Chin, G., Mihaly, E., Lin, J. M., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw8283 · Cited by 257
Self-citationLöscher, W., & Friedman, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020591 · Cited by 238
Self-citationBlood–brain barrier dysfunction, seizures and epilepsy
van Vliet, E. A., Aronica, E., & Gorter, J. A. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.10.003 · Cited by 228
Microglial calcium signaling is attuned to neuronal activity in awake mice
Umpierre, A. D., Bystrom, L. L., Ying, Y., Liu, Y., Worrell, G. A., & Wu, L. (2020) · eLife · doi:10.7554/elife.56502 · Cited by 214
Anti-Inflammatory Small Molecules To Treat Seizures and Epilepsy: From Bench to Bedside
Dey, A., Xu, K., Qiu, J., Du, Y., & Jiang, J. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.03.001 · Cited by 214
Inflammation and reactive oxygen species as disease modifiers in epilepsy
Terrone, G., Balosso, S., Pauletti, A., Ravizza, T., & Vezzani, A. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107742 · Cited by 212
Status epilepticus, blood–brain barrier disruption, inflammation, and epileptogenesis
Gorter, J. A., van Vliet, E. A., & Aronica, E. (2015) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2015.04.047 · Cited by 194
Neuroinflammatory targets and treatments for epilepsy validated in experimental models
Aronica, E., Bauer, S., Bozzi, Y., Caleo, M., Dingledine, R. J., Gorter, J. A., Henshall, D. C., Kaufer, D., Koh, S., Löscher, W., et al. (2017) · Epilepsia · doi:10.1111/epi.13783 · Cited by 194
Self-citationDreier, J. P., Lemâle, C. L., Kola, V., Friedman, A., & Schoknecht, K. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.09.027 · Cited by 188
Self-citationGDF10 is a signal for axonal sprouting and functional recovery after stroke
Li, S., Nie, E. H., Yin, Y., Benowitz, L. I., Tung, S., Vinters, H. V., Bahjat, F. R., Stenzel-Poore, M. P., Kawaguchi, R., Coppola, G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4146 · Cited by 181
Long-lasting blood-brain barrier dysfunction and neuroinflammation after traumatic brain injury
van Vliet, E. A., Ndode‐Ekane, X. E., Lehto, L. J., Gorter, J. A., Andrade, P., Aronica, E., Gröhn, O. H. J., & Pitkänen, A. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.105080 · Cited by 181
Löscher, W. (2016) · Epilepsy Research · doi:10.1016/j.eplepsyres.2016.05.016 · Cited by 155
mTOR and neuroinflammation in epilepsy: implications for disease progression and treatment
Ravizza, T., Scheper, M., Di Sapia, R., Gorter, J., Aronica, E., & Vezzani, A. (2024) · Nature Reviews Neuroscience · doi:10.1038/s41583-024-00805-1 · Cited by 141
Imaging blood–brain barrier dysfunction as a biomarker for epileptogenesis
Bar‐Klein, G., Lublinsky, S., Kamintsky, L., Noyman, I., Veksler, R., Dalipaj, H., Senatorov, V. V., Swissa, E., Rosenbach, D., Elazari, N., et al. (2017) · Brain · doi:10.1093/brain/awx073 · Cited by 139
Self-citationThe holy grail of epilepsy prevention: Preclinical approaches to antiepileptogenic treatments
Löscher, W. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.04.011 · Cited by 137
Kim, S. Y., Senatorov, V. V., Morrissey, C. S., Lippmann, K., Vazquez, O. N., Milikovsky, D. Z., Gu, F., Parada, I., Prince, D. A., Becker, A. J., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-07394-3 · Cited by 141
Self-citationTGF-β as a Key Modulator of Astrocyte Reactivity: Disease Relevance and Therapeutic Implications
Luo, J. (2022) · Biomedicines · doi:10.3390/biomedicines10051206 · Cited by 135
Mukhtar, I. (2020) · Seizure · doi:10.1016/j.seizure.2020.09.015 · Cited by 120
Prager, O., Kamintsky, L., Hasam‐Henderson, L. A., Schoknecht, K., Wuntke, V., Papageorgiou, I. E., Swolinsky, J. S., Muoio, V., Bar‐Klein, G., Vazana, U., et al. (2019) · Epilepsia · doi:10.1111/epi.14631 · Cited by 105
Self-citationMilikovsky, D. Z., Ofer, J., Senatorov, V. V., Friedman, A. R., Prager, O., Sheintuch, L., Elazari, N., Veksler, R., Zelig, D., Weissberg, I., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aaw8954 · Cited by 103
Self-citationNeuroinflammatory mediators in acquired epilepsy: an update
Chen, Y. S., Nagib, M. M., Yasmen, N., Sluter, M. N., Littlejohn, T. L., Yu, Y., & Jiang, J. (2023) · Inflammation Research · doi:10.1007/s00011-023-01700-8 · Cited by 101
Role of blood–brain barrier in temporal lobe epilepsy and pharmacoresistance
van Vliet, E. A., Aronica, E., & Gorter, J. A. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.07.030 · Cited by 100
Neuroinflammation in Post-Traumatic Epilepsy: Pathophysiology and Tractable Therapeutic Targets
Sharma, R., Leung, W. L., Zamani, A., O'Brien, T. J., Casillas-Espinosa, P. M., & Semple, B. D. (2019) · Brain Sciences · doi:10.3390/brainsci9110318 · Cited by 104
Repurposed molecules for antiepileptogenesis: Missing an opportunity to prevent epilepsy?
Klein, P., Friedman, A., Hameed, M. Q., Kaminski, R. M., Bar‐Klein, G., Klitgaard, H., Koepp, M. J., Jóźwiak, S., Prince, D. A., Rotenberg, A., et al. (2020) · Epilepsia · doi:10.1111/epi.16450 · Cited by 100
Self-citationBlood–brain barrier dysfunction in status epileptics: Mechanisms and role in epileptogenesis
Swissa, E., Serlin, Y., Vazana, U., Prager, O., & Friedman, A. (2019) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2019.04.038 · Cited by 97
Self-citationRavizza, T., & Vezzani, A. (2018) · Epilepsia Open · doi:10.1002/epi4.12242 · Cited by 96
Neuroinflammatory mechanisms of post-traumatic epilepsy
Mukherjee, S., Arisi, G. M., Mims, K., Hollingsworth, G., O’Neil, K., & Shapiro, L. A. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01854-w · Cited by 90
Preininger, M. K., & Kaufer, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23116217 · Cited by 87
Self-citationDong, X., Fan, J., Lin, D., Wang, X., Kuang, H., Gong, L., Chen, C., Jiang, J., Xia, N., He, D., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02587-8 · Cited by 82
Neuronal K+-Cl- cotransporter KCC2 as a promising drug target for epilepsy treatment
McMoneagle, E., Zhou, J. Q., Zhang, S., Huang, W., Josiah, S. S., Ding, K., Wang, Y., & Zhang, J. (2023) · Acta Pharmacologica Sinica · doi:10.1038/s41401-023-01149-9 · Cited by 78
Schoknecht, K., Prager, O., Vazana, U., Kamintsky, L., Harhausen, D., Zille, M., Figge, L., Chassidim, Y., Schellenberger, E. A., Kovács, R., et al. (2014) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2014.147 · Cited by 75
Self-citationIn search of antiepileptogenic treatments for post-traumatic epilepsy
Saletti, P. G., Ali, I. Y., Casillas-Espinosa, P. M., Semple, B. D., Lisgaras, C. P., Moshé, S. L., & Galanopoulou, A. S. (2018) · Neurobiology of Disease · doi:10.1016/j.nbd.2018.06.017 · Cited by 75
Korotkov, A., Broekaart, D. W. M., Banchaewa, L., Pustjens, B., van Scheppingen, J., Anink, J. J., Baayen, J. C., Idema, S., Gorter, J. A., van Vliet, E. A., et al. (2020) · Glia · doi:10.1002/glia.23700 · Cited by 70
Schoknecht, K., David, Y., & Heinemann, U. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.10.004 · Cited by 74
Self-citationThe role of inflammation in epileptogenesis
Meng, F., & Yao, L. (2020) · Acta Epileptologica · doi:10.1186/s42494-020-00024-y · Cited by 75
Neurovascular unit dysfunction as a mechanism of seizures and epilepsy during aging
van Vliet, E. A., & Marchi, N. (2022) · Epilepsia · doi:10.1111/epi.17210 · Cited by 69
Astrocytes as a target for therapeutic strategies in epilepsy: current insights
Çarçak, N., Onat, F., & Sitnikova, E. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1183775 · Cited by 70
Pharmacological modulation of cytokines correlating neuroinflammatory cascades in epileptogenesis
Vishwakarma, S., Singh, S., & Singh, T. G. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06896-8 · Cited by 69
Losartan ameliorates renal interstitial fibrosis through metabolic pathway and Smurfs-TGF-β/Smad
Zou, J., Zhou, X., Ma, Y., & Yu, R. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112931 · Cited by 66
Binder, D. K., & Steinhäuser, C. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03236-x · Cited by 70
Proteomic profiling of epileptogenesis in a rat model: Focus on inflammation
Walker, A., Russmann, V., Deeg, C. A., von Toerne, C., Kleinwort, K. J. H., Szober, C. M., Rettenbeck, M. L., von Rüden, E., Goc, J., Ongerth, T., et al. (2015) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2015.12.007 · Cited by 66
Isoflurane prevents acquired epilepsy in rat models of temporal lobe epilepsy
Bar‐Klein, G., Klee, R., Brandt, C., Bankstahl, M., Bascuñana, P., Töllner, K., Dalipaj, H., Bankstahl, J. P., Friedman, A., & Löscher, W. (2016) · Annals of Neurology · doi:10.1002/ana.24804 · Cited by 64
Self-citationGorter, J. A., Aronica, E., & van Vliet, E. A. (2019) · Epiliepsy currents/Epilepsy currents · doi:10.1177/1535759719844750 · Cited by 63
Bankstahl, M., Breuer, H., Leiter, I., Märkel, M., Bascuñana, P., Michalski, D., Bengel, F. M., Löscher, W., Meier, M., Bankstahl, J. P., et al. (2018) · eNeuro · doi:10.1523/eneuro.0123-18.2018 · Cited by 60
Differential TGF-β Signaling in Glial Subsets Underlies IL-6–Mediated Epileptogenesis in Mice
Levy, N., Milikovsky, D. Z., Baranauskas, G., Vinogradov, E., David, Y., Ketzef, M., Abutbul, S., Weissberg, I., Kamintsky, L., Fleidervish, I. A., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401446 · Cited by 58
Self-citationBekenstein, U., Mishra, N., Milikovsky, D. Z., Hanin, G., Zelig, D., Sheintuch, L., Berson, A., Greenberg, D., Friedman, A., & Soreq, H. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1701201114 · Cited by 59
Self-citationExpression and Function of Zinc-α2-Glycoprotein
Wei, X. P., Liu, X., Tan, C., Mo, L., Wang, H., Peng, X., Deng, F., & Chen, L. (2019) · Neuroscience Bulletin · doi:10.1007/s12264-018-00332-x · Cited by 59
Klément, W., Blaquière, M., Zub, E., de Bock, F., Boux, F., Barbier, E., Audinat, É., Lerner‐Natoli, M., & Marchi, N. (2019) · Epilepsia · doi:10.1111/epi.16019 · Cited by 66
Antiepileptogenic and neuroprotective effects of losartan in kainate model of temporal lobe epilepsy
Tchekalarova, J. D., Ivanova, N. M., Pechlivanova, D., Atanasova, D., Lazarov, N., Kortenska, L., Mitreva, R., Lozanov, V. S., & Stoynev, A. G. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.10.005 · Cited by 58
Recent advances in status epilepticus
Trinka, E., Brigo, F., & Shorvon, S. D. (2016) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000307 · Cited by 58
Anti-Epileptogenic Effects of Antiepileptic Drugs
Miziak, B., Konarzewska, A., Ułamek-Kozioł, M., Dudra-Jastrzębska, M., Pluta, R. M., & Czuczwar, S. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072340 · Cited by 58
Blood–Brain Barrier Imaging in Human Neuropathologies
Veksler, R., Shelef, I., & Friedman, A. (2014) · Archives of Medical Research · doi:10.1016/j.arcmed.2014.11.016 · Cited by 57
Self-citationElectrocorticographic Dynamics as a Novel Biomarker in Five Models of Epileptogenesis
Milikovsky, D. Z., Weissberg, I., Kamintsky, L., Lippmann, K., Schefenbauer, O., Frigerio, F., Rizzi, M., Sheintuch, L., Zelig, D., Ofer, J., et al. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.2446-16.2017 · Cited by 60
Self-citationvan Hameren, G., Aboghazleh, R., Parker, E., Dreier, J. P., Kaufer, D., & Friedman, A. (2024) · Nature Reviews Neurology · doi:10.1038/s41582-024-00973-9 · Cited by 61
Self-citationNo prevention or cure of epilepsy as yet
Klein, P., & Tyrlíková, I. (2019) · Neuropharmacology · doi:10.1016/j.neuropharm.2019.107762 · Cited by 55
Role of the Angiotensin Pathway and its Target Therapy in Epilepsy Management
Krasniqi, S., & Daci, A. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030726 · Cited by 54
Tchekalarova, J. D., Ivanova, N. M., Atanasova, D., Pechlivanova, D., Lazarov, N., Kortenska, L., Mitreva, R., Lozanov, V. S., & Stoynev, A. G. (2015) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-015-0278-3 · Cited by 52
Mechanisms of epileptogenesis and preclinical approach to antiepileptogenic therapies
Łukawski, K., Andres‐Mach, M., Czuczwar, M., Łuszczki, J. J., Kruszyński, K., & Czuczwar, S. J. (2017) · Pharmacological Reports · doi:10.1016/j.pharep.2017.07.012 · Cited by 57
Mendes, N. F., Pansani, A. P., Carmanhães, E. R. F., Tange, P., Meireles, J. V., Ochikubo, M., Chagas, J. R., da Silva, A. V., de Castro, G. M., & Sueur, L. D. P. L. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00382 · Cited by 52
Binder, D. K., & Steinhäuser, C. (2016) · Elsevier eBooks · doi:10.1016/c2014-0-03100-0 · Cited by 53
Thomas, M., Fronk, Z. K., Gross, A. J., Willmore, D. K., Arango, A., Higham, C., Nguyen, V. T., Lim, H. J., Kale, V. M., McMillan, G., et al. (2019) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2018.12.016 · Cited by 51
The neurovasculature as a target in temporal lobe epilepsy
Reiss, Y., Bauer, S., David, B., Devraj, K., Fidan, E., Hattingen, E., Liebner, S., Melzer, N., Meuth, S. G., Rosenow, F., et al. (2023) · Brain Pathology · doi:10.1111/bpa.13147 · Cited by 51
Understanding mechanisms of drug resistance in epilepsy and strategies for overcoming it
Łukawski, K., & Czuczwar, S. J. (2021) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2021.1959912 · Cited by 48
Lippmann, K., Kamintsky, L., Kim, S. Y., Lublinsky, S., Prager, O., Herzig-Nichtweiß, J. F., Salar, S., Kaufer, D., Heinemann, U., & Friedman, A. (2016) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x16652631 · Cited by 47
Self-citationYao, Y., Li, Y., Zeng, X., Ye, Z., Li, X., & Zhang, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01213 · Cited by 48
Singh, T., & Goel, R. K. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03274-5 · Cited by 51
Insulin Resistance and Blood-Brain Barrier Dysfunction Underlie Neuroprogression in Bipolar Disorder
Calkin, C., McClelland, C., Cairns, K., Kamintsky, L., & Friedman, A. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.636174 · Cited by 47
Self-citationA potential role for glia‐derived extracellular matrix remodeling in postinjury epilepsy
Kim, S. Y., Porter, B. E., Friedman, A., & Kaufer, D. (2016) · Journal of Neuroscience Research · doi:10.1002/jnr.23758 · Cited by 47
Self-citationNovel therapeutic targets for epilepsy intervention
Kambli, L., Bhatt, L. K., Oza, M. J., & Prabhavalkar, K. S. (2017) · Seizure · doi:10.1016/j.seizure.2017.07.014 · Cited by 47
Dexamethasone Attenuates Hyperexcitability Provoked by Experimental Febrile Status Epilepticus
Curran, M. M., Hall, A. M., Patterson, K. P., Shao, M., Eltom, N., Chen, K., Dubé, C. M., & Baram, T. Z. (2019) · eNeuro · doi:10.1523/eneuro.0430-19.2019 · Cited by 46
Should losartan be administered following brain injury?
Friedman, A., Bar-Klein, G., Serlin, Y., Parmet, Y., Heinemann, U., & Kaufer, D. (2014) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2014.972945 · Cited by 47
Self-citationSeizures and epilepsy in patients with ischaemic stroke
Zöllner, J. P., Schmitt, F. C., Rosenow, F., Kohlhase, K. D., Seiler, A., Strzelczyk, A., & Stefan, H. (2021) · Neurological Research and Practice · doi:10.1186/s42466-021-00161-w · Cited by 46
Emerging Molecular Targets for Anti-Epileptogenic and Epilepsy Modifying Drugs
Łukasiuk, K., & Lasoń, W. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032928 · Cited by 47
The Neuroinflammatory Role of Pericytes in Epilepsy
Yamanaka, G., Takata, F., Kataoka, Y., Kanou, K., Morıchı, S., Dohgu, S., & Kawashima, H. (2021) · Biomedicines · doi:10.3390/biomedicines9070759 · Cited by 44
The Renin Angiotensin System as a Therapeutic Target in Traumatic Brain Injury
Villapol, S., Janatpour, Z. C., Affram, K. O., & Symes, A. J. (2023) · Neurotherapeutics · doi:10.1007/s13311-023-01435-8 · Cited by 46
Salazar, A. Μ., & Grafman, J. H. (2015) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63521-1.00033-9 · Cited by 43
Bossuyt, J., Herrewegen, Y. V. D., Nestor, L., Buckinx, A., Bundel, D. D., & Smolders, I. J. (2023) · Glia · doi:10.1002/glia.24390 · Cited by 44
The Role of Neuroinflammation in Post-traumatic Epilepsy
Sun, L., Shan, W., Yang, H., Liu, R., Wu, J., & Wang, Q. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.646152 · Cited by 41
Inflammation in Epileptic Encephalopathies
Shandra, O. O., Moshé, S. L., & Galanopoulou, A. S. (2017) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2017.01.005 · Cited by 39
Blood-brain barrier dysfunction as a potential therapeutic target for neurodegenerative disorders
Uprety, A. R., Kang, Y., & Kim, S. Y. (2021) · Archives of Pharmacal Research · doi:10.1007/s12272-021-01332-8 · Cited by 39
Self-citationMorningstar, J. E., Nieman, A., Wang, C. E., Beck, T. C., Harvey, A., & Norris, R. A. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.121.020919 · Cited by 43
Preininger, M. K., Zaytseva, D., Lin, J. M., & Kaufer, D. (2023) · Aging Cell · doi:10.1111/acel.13747 · Cited by 36
Self-citationExploring the latest avenues for antiepileptic drug discovery and development
Łukawski, K., Gryta, P., Łuszczki, J. J., & Czuczwar, S. J. (2016) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2016.1154840 · Cited by 36
Zakrocka, I. N., Targowska‐Duda, K. M., Wnorowski, A., Kocki, T., Jóźwiak, K., & Turski, W. A. (2017) · Neurotoxicity Research · doi:10.1007/s12640-017-9781-2 · Cited by 36
Muneer, P. M. A., Bhowmick, S., & Briski, N. (2017) · Molecular Neurobiology · doi:10.1007/s12035-017-0812-z · Cited by 37
Liu, Y., Wang, T., Liu, X., Wen, Y., Xu, T., Yu, X., Wei, X. P., Ding, X., Mo, L., Yin, M., et al. (2018) · Journal of Neuroinflammation · doi:10.1186/s12974-018-1132-6 · Cited by 36
Mechanisms of microRNA-132 in central neurodegenerative diseases: A comprehensive review
Mu, C., Gao, M., Xu, W., Sun, X., Chen, T., Xu, H., & Qiu, H. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.116029 · Cited by 37
Role of blood–brain barrier dysfunction in the development of poststroke epilepsy
Meijer, W. C., & Gorter, J. A. (2024) · Epilepsia · doi:10.1111/epi.18072 · Cited by 36
Klee, R., Töllner, K., Rankovic, V., Römermann, K., Schidlitzki, A., Bankstahl, M., & Löscher, W. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2015.11.003 · Cited by 35
Prospects of epileptogenesis prevention
Radzik, I., Miziak, B., Dudka, J., Chrościńska–Krawczyk, M., & Czuczwar, S. J. (2015) · Pharmacological Reports · doi:10.1016/j.pharep.2015.01.016 · Cited by 34
Blood–brain barrier disruption and angiogenesis in a rat model for neurocysticercosis
Carmen‐Orozco, R. P., Dávila‐Villacorta, D. G., Cauna, Y., Bernal, E., Bitterfeld, L., Sutherland, G. L., Chile, N., Celiz, R. H., Ferrufino‐Schmidt, M. C., Gavidia, C. M., et al. (2018) · Journal of Neuroscience Research · doi:10.1002/jnr.24335 · Cited by 35
Epileptogenesis and oncogenesis: An antineoplastic role for antiepileptic drugs in brain tumours?
Cucchiara, F., Pasqualetti, F., Giorgi, F. S., Danesi, R., & Bocci, G. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104786 · Cited by 36
Prevalence and predictors of post-stroke epilepsy among Ghanaian stroke survivors
Sarfo, F. S., Akassi, J., Obese, V., Adamu, S., Agbenorku, M., & Ovbiagele, B. I. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117138 · Cited by 34
Metadata
- Authors
- Bar‐Klein, G., Cacheaux, L. P., Kamintsky, L., Prager, O., Weissberg, I., Schoknecht, K., Cheng, P., Kim, S. Y., Wood, L., Heinemann, U., Kaufer, D., & Friedman, A.
- Affiliations
- Ben-Gurion University of the Negev (IL)
- University of California, Berkeley (US)
- Departments of Physiology and Cell Biology Cognitive and Brain Sciences, Zlotowski Center for Neuroscience, Ben‐Gurion University of the Negev Beer‐Sheva Israel
- Charité – Universitätsmedizin Berlin (DE)
- Helen Wills Neuroscience Institute and Department of Integrative Biology University of California, Berkeley Berkeley CA
- Corresponding author
- Friedman, Alon
- ORCID
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2014-05-28
- Volume
- 75
- Issue
- 6
- Pages
- 864-875
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- PMC
- PMC4077937
- OpenAlex
- W1746603715
- Cited by
- 270
- References
- 63
- Citations by year
- 2026: 18 · 2025: 11 · 2024: 28 · 2023: 24 · 2022: 23 · 2021: 26 · 2020: 29 · 2019: 30 · 2018: 15 · 2017: 26 · 2016: 17 · 2015: 13 · 2014: 10
- FWCI
- 16.78
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Annals of Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (RO1/NINDS NS066005)
- United States - Israel Binational Science Foundation (2007185)
- Israel Science Foundation (713/11)
- The European Unions Seventh Framework Program (FP7/2007-2013), EPITARGET (602102)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Epilepsy research and treatment
- Health Sciences › Medicine › Clinical Neurology › Traumatic Brain Injury and Neurovascular Disturbances
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- losartan, acquired epilepsy, epileptogenesis, TGF-beta signaling, serum albumin, vascular injury, angiotensin II type 1 receptor, ALK5, astrocytes, blood-brain barrier permeability, vascular reactivity, antiepileptogenic therapy, spontaneous seizures, electrocorticography
- MeSH terms
- Animals, Animals, Newborn, Anticonvulsants, Astrocytes, Benzamides, Blood-Brain Barrier, Cells, Cultured, Cerebral Cortex, Dioxoles, Disease Models, Animal, Embryo, Mammalian, Endocytosis, Epilepsy, Male, Neurons, Phosphopyruvate Hydratase, Signal Transduction, Transforming Growth Factor beta, Rats, Wistar, Losartan, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
